News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
224,580 Results
Type
Article (5005)
Company Profile (17)
Press Release (219558)
Section
Business (82199)
Career Advice (461)
Deals (15042)
Drug Delivery (8)
Drug Development (19061)
Employer Resources (30)
FDA (3674)
Job Trends (3900)
News (120099)
Policy (7499)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (293)
Adcomms (3)
Allergies (9)
Alliances (14759)
ALS (18)
Alzheimer's disease (241)
Antibody-drug conjugate (ADC) (10)
Approvals (3688)
Artificial intelligence (39)
Autoimmune disease (2)
Automation (2)
Bankruptcy (97)
Best Places to Work (2862)
Biosimilars (11)
Biotechnology (21)
Bladder cancer (9)
Brain cancer (7)
Breast cancer (45)
Cancer (418)
Cardiovascular disease (19)
Career advice (391)
Career pathing (2)
CAR-T (29)
Cell therapy (100)
Cervical cancer (2)
Clinical research (15989)
Collaboration (161)
Compensation (144)
Complete response letters (2)
COVID-19 (301)
CRISPR (7)
C-suite (88)
Cystic fibrosis (16)
Data (478)
Depression (5)
Diabetes (37)
Diagnostics (2035)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (15)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (40680)
Editorial (1)
Employer branding (6)
Employer resources (31)
Events (37621)
Executive appointments (277)
FDA (3902)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (173)
Gene editing (15)
Generative AI (2)
Gene therapy (43)
GLP-1 (103)
Government (407)
Guidances (16)
Healthcare (5035)
Huntington's disease (1)
IgA nephropathy (2)
Immunology and inflammation (13)
Indications (6)
Infectious disease (316)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (53)
IPO (7815)
IRA (3)
Job creations (1120)
Job search strategy (360)
Kidney cancer (6)
Labor market (4)
Layoffs (100)
Leadership (4)
Legal (2330)
Liver cancer (17)
Lung cancer (49)
Lymphoma (25)
Management (10)
Manufacturing (45)
MASH (26)
Medical device (3855)
Medtech (3856)
Mergers & acquisitions (7416)
Metabolic disorders (111)
Multiple sclerosis (8)
NASH (6)
Neurodegenerative disease (8)
Neuropsychiatric disorders (1)
Neuroscience (326)
NextGen: Class of 2025 (1675)
Non-profit (727)
Northern California (854)
Now hiring (2)
Obesity (50)
Opinion (30)
Ovarian cancer (17)
Pain (12)
Pancreatic cancer (13)
Parkinson's disease (20)
Partnered (4)
Patents (21)
Patient recruitment (26)
Peanut (5)
People (24498)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (4765)
Phase II (6941)
Phase III (5535)
Pipeline (485)
Policy (4)
Postmarket research (625)
Preclinical (1860)
Press Release (66)
Prostate cancer (26)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (63)
Real estate (1872)
Recruiting (8)
Regulatory (5091)
Reports (14)
Research institute (300)
Resumes & cover letters (68)
Rett syndrome (2)
Schizophrenia (20)
Series A (25)
Series B (21)
Sickle cell disease (7)
Southern California (660)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (3)
Startups (1007)
Stomach cancer (1)
Supply chain (10)
United States (6571)
Vaccines (33)
Venture capitalists (2)
Webinars (4)
Weight loss (19)
Women's health (1)
Date
Today (29)
Last 7 days (206)
Last 30 days (822)
Last 365 days (10274)
2025 (2381)
2024 (11034)
2023 (13195)
2022 (18659)
2021 (19680)
2020 (18239)
2019 (13208)
2018 (10205)
2017 (10003)
2016 (9158)
2015 (12119)
2014 (9587)
2013 (7707)
2012 (8329)
2011 (8796)
2010 (8634)
Location
Africa (183)
Alabama (13)
Alaska (2)
Arizona (58)
Arkansas (1)
Asia (11427)
Australia (1599)
California (1795)
Canada (661)
China (66)
Colorado (76)
Connecticut (90)
Delaware (27)
Europe (24410)
Florida (248)
Georgia (32)
Idaho (23)
Illinois (108)
India (5)
Indiana (59)
Iowa (1)
Japan (63)
Kansas (24)
Kentucky (10)
Louisiana (5)
Maine (38)
Maryland (214)
Massachusetts (1439)
Michigan (84)
Minnesota (133)
Mississippi (1)
Missouri (21)
Montana (16)
Nebraska (12)
Nevada (22)
New Hampshire (15)
New Jersey (526)
New Mexico (5)
New York (446)
North Carolina (312)
North Dakota (2)
Northern California (854)
Ohio (53)
Oklahoma (5)
Oregon (3)
Pennsylvania (328)
Rhode Island (11)
South America (275)
South Carolina (4)
Southern California (660)
Tennessee (34)
Texas (212)
Utah (57)
Virginia (39)
Washington D.C. (8)
Washington State (156)
West Virginia (2)
Wisconsin (20)
224,580 Results for "glaukos corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
RadiusXR and Glaukos Corporation Announce a New Collaboration With Topcon Healthcare, Inc. and the Launch of Inspire®: A Next-Generation Visual Field Solution
March 11, 2025
·
7 min read
Press Releases
Glaukos Announces FDA Acceptance of NDA Submission for Epioxa™
February 24, 2025
·
6 min read
Press Releases
Glaukos Announces Fourth Quarter and Full Year 2024 Financial Results
February 21, 2025
·
18 min read
Biotech Beach
Glaukos Announces Participation in Upcoming Investor Conferences - May 28, 2024
Glaukos Corporation today announced that its management is scheduled to participate in the following upcoming investor conferences.
May 28, 2024
·
1 min read
Press Releases
Glaukos Announces Participation in the J.P. Morgan Healthcare Conference
December 17, 2024
·
1 min read
Press Releases
Glaukos Submits New Drug Application to U.S. FDA for Epioxa™
December 23, 2024
·
5 min read
Press Releases
Glaukos Announces Participation in Upcoming Investor Conferences
November 8, 2024
·
1 min read
Press Releases
Glaukos to Release Fourth Quarter and Full Year 2024 Financial Results after Market Close on February 20
January 23, 2025
·
1 min read
Press Releases
Glaukos Announces Positive Clinical Updates for its iDose® Sustained-Release Procedural Pharmaceutical Platform
January 14, 2025
·
7 min read
Business
Glaukos Announces First Quarter 2024 Financial Results
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financial results for the first quarter ended March 31, 2024.
May 1, 2024
·
14 min read
1 of 22,458
Next
